down arrow

Suven Life Scie.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE495B01038
  • NSEID: SUVEN
  • BSEID: 530239
INR
122.50
2.95 (2.47%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.44 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

121.45125.25

52 Week

83.27169.00
Valuation
Technical
Day's Volume

CASH

2.44 lacs (-61.70%) Volume

Shareholding (Dec 2024)

FII

0.34%

Held by 14 FIIs

DII

1.06%

Held by 1 DIIs

Promoter

70.27%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of -55.94% and Operating profit at -216.84% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -126.12
2

Negative results in Dec 24

3

Stock is technically in a Bearish range

4

Risky - Negative EBITDA

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 2,671 Cr (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.86

stock-summary
Return on Equity

-75.76%

stock-summary
Price to Book

13.53

Revenue and Profits (1 Year):
Net Sales:
2 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-39 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-13.12%
0%
-13.12%
1 Year
4.4%
0%
4.4%
2 Years
126.35%
0%
126.35%
3 Years
27.34%
0%
27.34%
4 Years
49.76%
0%
49.76%
5 Years
396.96%
0%
396.96%

Latest dividend: 1.5 per share ex-dividend date: Feb-14-2019

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-55.94%
EBIT Growth (5y)
-216.84%
EBIT to Interest (avg)
-126.12
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.31
Tax Ratio
0.69%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.39%
ROCE (avg)
-123.95%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
13.53
EV to EBIT
-15.43
EV to EBITDA
-16.03
EV to Capital Employed
92.32
EV to Sales
322.01
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-625.11%
ROE (Latest)
-75.76%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 4 Schemes (1.05%)

FIIs

Held by 14 FIIs (0.34%)

Promoter with highest holding

Jasti Property And Equity Holdings Private Limited (initscapacityassoletrusteeofjastifamilytrust) (69.56%)

Highest Public shareholder

Rambabu Chirumamilla (1.38%)

Individual Investors Holdings

22.31%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -37.35% vs 154.46% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 21.19% vs -77.03% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.61",
          "val2": "2.57",
          "chgp": "-37.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-39.21",
          "val2": "-52.21",
          "chgp": "24.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.02",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-39.12",
          "val2": "-49.64",
          "chgp": "21.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,435.40%",
          "val2": "-2,031.52%",
          "chgp": "-403.88%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -47.81% vs -13.49% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -111.26% vs 6.93% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.58",
          "val2": "6.86",
          "chgp": "-47.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-82.75",
          "val2": "-51.52",
          "chgp": "-60.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.04",
          "val2": "0.09",
          "chgp": "-55.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-77.68",
          "val2": "-36.77",
          "chgp": "-111.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,311.45%",
          "val2": "-751.02%",
          "chgp": "-1,560.43%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -44.25% vs -14.82% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -48.73% vs 13.35% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.19",
          "val2": "9.31",
          "chgp": "-44.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-121.96",
          "val2": "-97.72",
          "chgp": "-24.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.05",
          "val2": "0.13",
          "chgp": "-61.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-116.80",
          "val2": "-78.53",
          "chgp": "-48.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,349.90%",
          "val2": "-1,049.62%",
          "chgp": "-1,300.28%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -13.66% vs 14.36% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 11.15% vs 3.06% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11.69",
          "val2": "13.54",
          "chgp": "-13.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-128.01",
          "val2": "-125.89",
          "chgp": "-1.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.16",
          "val2": "0.29",
          "chgp": "-44.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.46",
          "val2": "6.00",
          "chgp": "24.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-105.08",
          "val2": "-118.27",
          "chgp": "11.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,095.04%",
          "val2": "-929.76%",
          "chgp": "-165.28%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
1.61
2.57
-37.35%
Operating Profit (PBDIT) excl Other Income
-39.21
-52.21
24.90%
Interest
0.01
0.02
-50.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-39.12
-49.64
21.19%
Operating Profit Margin (Excl OI)
-2,435.40%
-2,031.52%
-403.88%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -37.35% vs 154.46% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 21.19% vs -77.03% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
3.58
6.86
-47.81%
Operating Profit (PBDIT) excl Other Income
-82.75
-51.52
-60.62%
Interest
0.04
0.09
-55.56%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-77.68
-36.77
-111.26%
Operating Profit Margin (Excl OI)
-2,311.45%
-751.02%
-1,560.43%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -47.81% vs -13.49% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -111.26% vs 6.93% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
5.19
9.31
-44.25%
Operating Profit (PBDIT) excl Other Income
-121.96
-97.72
-24.81%
Interest
0.05
0.13
-61.54%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-116.80
-78.53
-48.73%
Operating Profit Margin (Excl OI)
-2,349.90%
-1,049.62%
-1,300.28%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -44.25% vs -14.82% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -48.73% vs 13.35% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
11.69
13.54
-13.66%
Operating Profit (PBDIT) excl Other Income
-128.01
-125.89
-1.68%
Interest
0.16
0.29
-44.83%
Exceptional Items
7.46
6.00
24.33%
Consolidate Net Profit
-105.08
-118.27
11.15%
Operating Profit Margin (Excl OI)
-1,095.04%
-929.76%
-165.28%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -13.66% vs 14.36% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 11.15% vs 3.06% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Suven Life Sciences Ltd stock-summary
stock-summary
Suven Life Sciences Ltd
Small Cap
Pharmaceuticals & Drugs
Suven Life Sciences Limited (Formerly known as Suven Pharmaceuticals Ltd) was incorporated in March, 1989. The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003. Promoted by Sudharani Jasti and Venkateswarlu Jasti, the Company began operations in 1989 as specialty chemicals provider.
Company Coordinates stock-summary
Company Details
#8-2-334 SDE Serene Chambers, 6 th Floor Road No 5 Avenue 7 Hyderabad Telangana : 500034
stock-summary
Tel: 91-40-23541142/3311/3315
stock-summary
http://www.suven.com
stock-summary
info@suven.com
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."